rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
1989-11-28
|
pubmed:abstractText |
In 40 patients with bacterial bronchopulmonary complications during polychemotherapy for advanced bronchogenic carcinoma, once-daily netilmicin (4.5 mg/kg every 24 h) brought about complete resolution of the infective process in 90% of the cases and eradication of the responsible pathogen in 82%. This result must be considered good in view of the patients' precarious condition due to their advanced neoplastic disease.
|
pubmed:language |
ita
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0009-9074
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
130
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
267-70
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:2530029-Adult,
pubmed-meshheading:2530029-Aged,
pubmed-meshheading:2530029-Carcinoma, Bronchogenic,
pubmed-meshheading:2530029-Drug Evaluation,
pubmed-meshheading:2530029-Female,
pubmed-meshheading:2530029-Humans,
pubmed-meshheading:2530029-Lung Neoplasms,
pubmed-meshheading:2530029-Male,
pubmed-meshheading:2530029-Middle Aged,
pubmed-meshheading:2530029-Netilmicin,
pubmed-meshheading:2530029-Respiratory Tract Infections
|
pubmed:year |
1989
|
pubmed:articleTitle |
[Netilmicin in single daily doses for the bacterial bronchopulmonary complications in patients with advanced bronchogenic carcinoma].
|
pubmed:publicationType |
Journal Article,
English Abstract
|